Is ImmunoBiological stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, ImmunoBiological pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Wednesday 27th of March 2013 were paid JPY5 per share. Over the last 1 times between 2013 and 2013, ImmunoBiological has paid JPY5 with an average of JPY5 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for ImmunoBiological 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was JPY721.00, you would have made a loss of JPY-221.00 per share or -30.65%
Yes, the average daily trading liquidity for ImmunoBiological is JPY294 355 thousand. You should therefore be able to get in and out of your positions relatively fast.
ImmunoBiological has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. ImmunoBiological has a very good net profit margin of 26.08% and should have very high tolerances against inflation.
We have calculated the inflation risk for ImmunoBiological to be low [0.45 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.